Our vision is to redefine the landscape of therapeutic targets that can be addressed by small molecule drugs.

We achieve this by using our innovative discovery platform to identify functional Microcycle hits against targets within their native intracellular environment.

We are using these functional hits to design and develop a pipeline new small molecule drugs against high priority cancer targets.